KBM
- Dec 18, 2019
- 1 min read

AORN and SGNA Public Advisory Meeting with FDA

SGNA and AORN leadership recently spoke at the public advisory committee of the FDA to address the nursing perspective and effective solutions regarding the issues with duodenoscope-related transmission of pathogens. Here are the summary sites:

https://www.fda.gov/media/132494/download

https://theinsidetract.sgna.org/Article/ArtMID/385/ArticleID/197/SGNA-and-AORN-on-FDA-and-Duodenoscope-Reprocessing

Recent Posts

See All

FDA Recognizes Vaporized Hydrogen Peroxide for Sterilization.

The FDA has now finalized the 2024 guidance for 510(k) information required for sterilization of reusable medical devices with some exclusions. (See https://www.fda.gov/media/74445/download?attachment

Have You Evaluated Your Patient Care Contracts?

This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific, measurable, attainable, relevant, and timely (SMART) key performanc

Masking in Healthcare Facilities

Post: Blog2_Post